
Unirab 20mg Injection
Marketer
United Biotech Pvt Ltd
Salt Composition
Rabeprazole (20mg)
Overview Unirab 20mg Injection
AcidZest 20mg Injection reduces stomach acid production, treating acid-related gastrointestinal disorders like reflux, indigestion, peptic ulcers, and other conditions stemming from excess acid. Its rapid action offers swift relief from acidity. Used prophylactically for stress ulcers in critically ill patients and pre-anesthesia to mitigate aspiration risks, AcidZest 20mg is a proton pump inhibitor (PPI) administered intravenously by a healthcare professional only when deemed more appropriate than oral medication. Dosage and treatment duration are determined by your physician based on your condition and response. Consistent use as prescribed is crucial, even with rapid symptom resolution. Optimizing treatment involves smaller, more frequent meals, and avoiding caffeine, spicy, and fatty foods. Common, usually mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, stomach pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant medical attention. Prolonged use (over a year) may increase bone fracture risk, particularly at higher doses. Discuss bone loss prevention strategies, such as calcium and vitamin D supplementation, with your doctor. Hypomagnesemia (low magnesium) has been linked to use exceeding three months, potentially causing fatigue, confusion, dizziness, muscle spasms, and arrhythmias. Your doctor may monitor magnesium levels. AcidZest 20mg is unsuitable for individuals with severe liver disease, those on HIV medications, those with prior PPI allergies, or existing osteoporosis. Pregnant or breastfeeding individuals require medical consultation before use. Alcohol consumption should be avoided due to its acid-stimulating effects. Refrain from operating machinery if dizziness or drowsiness occurs.
Primary Ingredients of Unirab 20mg Injection
No text was provided to rewrite.
Uses of Unirab 20mg Injection
Management of acid indigestion and peptic ulcers.
Major Benefits of Unirab 20mg Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
Common Side effects of Unirab 20mg Injection:
- Nausea
- Vomiting
- Headache
- Dizziness
- Flatulence
- Diarrhea
- Stomach pain
- Thrombophlebitis
How to use Unirab 20mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Unirab 20mg Injection works:
Gastric acid secretion is diminished by the proton pump inhibitor Unirab 20mg Injection, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Unirab 20mg Injection concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Unirab 20mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Unirab 20mg Injection while breastfeeding is likely inadvisable. Available evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Unirab 20mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Unirab 20mg Injection presents a safe treatment option; dosage modification is unnecessary.
LiverCAUTION
For patients with severe hepatic impairment, administering Unirab 20mg Injection requires careful consideration and potential dosage modification. Physician consultation is recommended.
What if you forget to take Unirab 20mg Injection :
Omit a scheduled Unirab 20mg Injection? Seek medical advice immediately.
Facts to Know About Unirab 20mg Injection
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal System |
| Active Class | Gastric acid suppressants |
